{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/69fc494f8c59df7dd5266374/6a06cdfdefd1f558b076f38a?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Rapportkommentar - första kvartalet 2026","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/69fc494f8c59df7dd5266374/1778830663461-7955648b-0644-4e9e-b9c2-4f427bf3c00f.jpeg?height=200","description":"<p>Oncopeptides vd Sofia Heigis och CFO Henrik Bergentoft kommenterar rapporten för det första kvartalet 2026.</p><p><br></p><p>Musik: Michael Rothery - Not a game / Epidemic Sound, Martin Landström – Honey I'm Home / Epidemic Sound</p>","author_name":"Furelid Communications"}